首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1386359

口干症治疗市场报告：2030 年趋势、预测与竞争分析

Xerostomia Therapeutic Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: 2023年10月03日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

口干症治疗的趋势与预测

预计到 2030 年，全球口干症治疗市场将达到约 11 亿美元，2024 年至 2030 年复合年增长率为 3.5%。该市场的主要驱动因素是对口干症治疗的需求不断增长、新型和创新性口干症治疗的市场开拓不断增加以及对口干症的认识不断提高。全球口干症药物市场的未来看起来充满希望，有成药和处方药应用的机会。

口干症治疗市场洞察

Lucintel 预测，人造唾液的使用量将更高，因为其表现与天然唾液相似，预计在预测期内将出现最高成长。

由于人口口干病例增加以及该地区先进治疗方案的可用性，预计北美在预测期内将出现最高的增长。

本报告回答了 11 个关键问题：

Q.1. 细分市场中最有前途和高成长的机会是什么？
Q.2.哪个细分市场将以更快的速度成长？为什么？
Q.3.您认为哪些地区未来会出现更快的成长？为什么？
Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
Q.5. 这个市场的商业风险和竞争威胁是什么？
Q.6.这个市场有哪些新趋势？为什么？
Q.7.市场客户需求有何改变？
Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
Q.11.过去五年发生了哪些併购事件，对产业产生了哪些影响？

宏观经济趋势（2018-2023）与预测（2024-2030）
全球口干症治疗市场趋势（2018-2023）与预测（2024-2030）
按产品类型分類的全球口干症治疗市场
- 人工唾液
- 牙膏
- 唾液分泌兴奋剂
- 唾液替代品
- 药物
- 唾液笔
全球口干症治疗市场（按应用）
- 在商店
- 处方笺

第四章 2018-2030年区域市场趋势及预测分析

按地区分類的全球口干症治疗市场
北美口干症治疗市场
欧洲口干症治疗市场
亚太地区口干症治疗市场
其他区域性口干症治疗市场

第五章竞争分析

产品系列分析
营运整合
波特五力分析

第六章成长机会与策略分析

成长机会分析
- 按产品类型分類的全球口干症治疗市场成长机会
- 全球口干症治疗市场成长机会（按应用）
- 全球口干症治疗市场成长机会（按地区）
全球口干症治疗市场的新兴趋势
战略分析
- 新产品开发
- 扩大全球口干症治疗市场的产能
- 全球口干症治疗市场的合併、收购与合资企业
- 认证和许可

第七章主要企业概况

GlaxoSmithKline
Church & Dwight
Colgate-Palmolive
Hikma Pharmaceuticals
Pendopharm
Sun Pharmaceuticals
Lupin Pharmaceuticals
Pfizer
Parnell Pharmaceuticals
Acacia Pharma

简介目录

Xerostomia Therapeutic Trends and Forecast

The future of the global xerostomia therapeutic market looks promising with opportunities in the over the counter and prescription applications. The global xerostomia therapeutic market is expected to reach an estimated $1.1 billion by 2030 with a CAGR of 3.5% from 2024 to 2030. The major drivers for this market are growing demand for xerostomia treatments, rising development of new and innovative xerostomia treatments, and increasing awareness of xerostomia.

A more than 150-page report is developed to help in your business decisions.

Xerostomia Therapeutic by Segment

The study includes a forecast for the global xerostomia therapeutic by product type, application, and region.

Xerostomia Therapeutic Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

Artificial Saliva
Dentifrices
Salivary Stimulants
Saliva Substitutes
Drugs
Salivary Pen

Xerostomia Therapeutic Market by Application [Shipment Analysis by Value from 2018 to 2030]:

Over The Counter
Prescription

Xerostomia Therapeutic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

North America
Europe
Asia Pacific
The Rest of the World

List of Xerostomia Therapeutic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies xerostomia therapeutic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the xerostomia therapeutic companies profiled in this report include-

GlaxoSmithKline
Church & Dwight
Colgate-Palmolive
Hikma Pharmaceuticals
Pendopharm
Sun Pharmaceuticals
Lupin Pharmaceuticals
Pfizer
Parnell Pharmaceuticals
Acacia Pharma

Xerostomia Therapeutic Market Insights

Lucintel forecasts that artificial saliva is expected to witness highest growth over the forecast period due to its significant usage to perform similarly to natural saliva.

North America is expected to witness highest growth over the forecast period due to the growing cases of dry mouth among population and availability of advanced treatment options in the region.

Features of the Global Xerostomia Therapeutic Market

Market Size Estimates: Xerostomia therapeutic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Xerostomia therapeutic market size by product type, application, and region in terms of value ($B).

Regional Analysis: Xerostomia therapeutic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, applications, and regions for the xerostomia therapeutic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the xerostomia therapeutic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the xerostomia therapeutic market size?

Answer: The global xerostomia therapeutic market is expected to reach an estimated $1.1 billion by 2030.

Q.2 What is the growth forecast for xerostomia therapeutic market?

Answer: The global xerostomia therapeutic market is expected to grow with a CAGR of 3.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the xerostomia therapeutic market?

Answer: The major drivers for this market are growing demand for xerostomia treatments, rising development of new and innovative xerostomia treatments, and increasing awareness of xerostomia.

Q4. What are the major segments for xerostomia therapeutic market?

Answer: The future of the xerostomia therapeutic market looks promising with opportunities in the over the counter and prescription applications.

Q5. Who are the key xerostomia therapeutic market companies?

Answer: Some of the key xerostomia therapeutic companies are as follows:

GlaxoSmithKline
Church & Dwight
Colgate-Palmolive
Hikma Pharmaceuticals
Pendopharm
Sun Pharmaceuticals
Lupin Pharmaceuticals
Pfizer
Parnell Pharmaceuticals
Acacia Pharma

Q6. Which xerostomia therapeutic market segment will be the largest in future?

Answer: Lucintel forecasts that artificial saliva is expected to witness highest growth over the forecast period due to its significant usage to perform similarly to natural saliva.

Q7. In xerostomia therapeutic market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to the growing cases of dry mouth among population and availability of advanced treatment options in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the xerostomia therapeutic market by product type (artificial saliva, dentifrices, salivary stimulants, saliva substitutes, drugs, and salivary pen), application (over the counter and prescription), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Global Xerostomia Therapeutic Market : Market Dynamics

2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Xerostomia Therapeutic Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Xerostomia Therapeutic Market by Product Type
- 3.3.1: Artificial Saliva
- 3.3.2: Dentifrices
- 3.3.3: Salivary Stimulants
- 3.3.4: Saliva Substitutes
- 3.3.5: Drugs
- 3.3.6: Salivary Pen
3.4: Global Xerostomia Therapeutic Market by Application
- 3.4.1: Over The Counter
- 3.4.2: Prescription

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

4.1: Global Xerostomia Therapeutic Market by Region
4.2: North American Xerostomia Therapeutic Market
- 4.2.2: North American Xerostomia Therapeutic Market by Application: Over The Counter and Prescription
4.3: European Xerostomia Therapeutic Market
- 4.3.1: European Xerostomia Therapeutic Market by Product Type: Artificial Saliva, Dentifrices, Salivary Stimulants, Saliva Substitutes, Drugs, and Salivary Pen
- 4.3.2: European Xerostomia Therapeutic Market by Application: Over The Counter and Prescription
4.4: APAC Xerostomia Therapeutic Market
- 4.4.1: APAC Xerostomia Therapeutic Market by Product Type: Artificial Saliva, Dentifrices, Salivary Stimulants, Saliva Substitutes, Drugs, and Salivary Pen
- 4.4.2: APAC Xerostomia Therapeutic Market by Application: Over The Counter and Prescription
4.5: ROW Xerostomia Therapeutic Market
- 4.5.1: ROW Xerostomia Therapeutic Market by Product Type: Artificial Saliva, Dentifrices, Salivary Stimulants, Saliva Substitutes, Drugs, and Salivary Pen
- 4.5.2: ROW Xerostomia Therapeutic Market by Application: Over The Counter and Prescription

5. Competitor Analysis

5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

6.1: Growth Opportunity Analysis
- 6.1.1: Growth Opportunities for the Global Xerostomia Therapeutic Market by Product Type
- 6.1.2: Growth Opportunities for the Global Xerostomia Therapeutic Market by Application
- 6.1.4: Growth Opportunities for the Global Xerostomia Therapeutic Market by Region
6.2: Emerging Trends in the Global Xerostomia Therapeutic Market
6.3: Strategic Analysis
- 6.3.1: New Product Development
- 6.3.2: Capacity Expansion of the Global Xerostomia Therapeutic Market
- 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Xerostomia Therapeutic Market
- 6.3.4: Certification and Licensing